Murat Bardakçı

9PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMedical biotechnology not elsewhere classifiedMedical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 16, 2026
Comparative Safety Profiles of Sacituzumab Govitecan and Datopotamab Deruxtecan: A Real-World Pharmacovigilance Study.

|Jun 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

|Nov 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638.

Ziya Kalkan, Senar Ebinc, Murat Arcagok

|Aug 28, 2025
Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis.

Emre Hafızoğlu, Murat Bardakçı, Yakup Ergun

|Jun 27, 2025
"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

Serkan Yaşar, Ahmet Kadıoğlu, Arif Akyildiz

|Apr 26, 2025
Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective Cohort.

Emre Hafızoğlu, Murat Bardakçı, Yakup Ergun

Pageof 2

Frequent Collaborators

4 joint publications

Öznur Bal

3 joint publications

Doğan Bayram

3 joint publications

Yakup Ergun

3 joint publications

Fahriye Tuğba Köş